These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31494470)

  • 1. Highly potent non-steroidal FXR agonists protostane-type triterpenoids: Structure-activity relationship and mechanism.
    Luan ZL; Huo XK; Dong PP; Tian XG; Sun CP; Lv X; Feng L; Ning J; Wang C; Zhang BJ; Ma XC
    Eur J Med Chem; 2019 Nov; 182():111652. PubMed ID: 31494470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alisma orientale extract exerts the reversing cholestasis effect by activation of farnesoid X receptor.
    Huo XK; Liu J; Yu ZL; Wang YF; Wang C; Tian XG; Ning J; Feng L; Sun CP; Zhang BJ; Ma XC
    Phytomedicine; 2018 Mar; 42():34-42. PubMed ID: 29655695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triterpenes from Alisma orientalis act as farnesoid X receptor agonists.
    Lin HR
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4787-92. PubMed ID: 22683342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending the structure-activity relationship of anthranilic acid derivatives as farnesoid X receptor modulators: development of a highly potent partial farnesoid X receptor agonist.
    Merk D; Lamers C; Ahmad K; Carrasco Gomez R; Schneider G; Steinhilber D; Schubert-Zsilavecz M
    J Med Chem; 2014 Oct; 57(19):8035-55. PubMed ID: 25255039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).
    Tully DC; Rucker PV; Chianelli D; Williams J; Vidal A; Alper PB; Mutnick D; Bursulaya B; Schmeits J; Wu X; Bao D; Zoll J; Kim Y; Groessl T; McNamara P; Seidel HM; Molteni V; Liu B; Phimister A; Joseph SB; Laffitte B
    J Med Chem; 2017 Dec; 60(24):9960-9973. PubMed ID: 29148806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties.
    Flesch D; Gabler M; Lill A; Gomez RC; Steri R; Schneider G; Stark H; Schubert-Zsilavecz M; Merk D
    Bioorg Med Chem; 2015 Jul; 23(13):3490-8. PubMed ID: 25934227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protostane-Type Triterpenoids from Alisma orientale.
    Li HM; Chen XJ; Luo D; Fan M; Zhang ZJ; Peng LY; Wu XD; Li RT; Ji X; Zhao QS
    Chem Biodivers; 2017 Dec; 14(12):. PubMed ID: 29139211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarmentol H derived from Sedum sarmentosum Bunge directly targets FXR to mitigate cholestasis by recruiting SRC-1.
    Liu Z; Chen L; Chen M; Linghu L; Liao Z; Chen M; Wang G
    Phytomedicine; 2024 Jul; 130():155759. PubMed ID: 38788394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural optimization and in vitro profiling of N-phenylbenzamide-based farnesoid X receptor antagonists.
    Schmidt J; Schierle S; Gellrich L; Kaiser A; Merk D
    Bioorg Med Chem; 2018 Aug; 26(14):4240-4253. PubMed ID: 30026040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator.
    Luo G; Lin X; Li Z; Xiao M; Li X; Zhang D; Xiang H
    Eur J Med Chem; 2021 Jan; 209():112910. PubMed ID: 33049605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR).
    Merk D; Gabler M; Gomez RC; Flesch D; Hanke T; Kaiser A; Lamers C; Werz O; Schneider G; Schubert-Zsilavecz M
    Bioorg Med Chem; 2014 Apr; 22(8):2447-60. PubMed ID: 24685112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Optimization of Non-bile Acid FXR Agonists as Preclinical Candidates for the Treatment of Nonalcoholic Steatohepatitis.
    Li J; Liu M; Li Y; Sun DD; Shu Z; Tan Q; Guo S; Xie R; Gao L; Ru H; Zang Y; Liu H; Li J; Zhou Y
    J Med Chem; 2020 Nov; 63(21):12748-12772. PubMed ID: 32991173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease.
    Qin T; Gao X; Lei L; Feng J; Zhang W; Hu Y; Shen Z; Liu Z; Huan Y; Wu S; Xia J; Zhang L
    Eur J Med Chem; 2023 Apr; 252():115307. PubMed ID: 37003047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and identification of a new farnesoid X receptor (FXR) partial agonist by computational structure-activity relationship analysis: Ligand-induced H8 helix fluctuation in the ligand-binding domain of FXR may lead to partial agonism.
    Gohda K; Iguchi Y; Masuda A; Fujimori K; Yamashita Y; Teno N
    Bioorg Med Chem Lett; 2021 Jun; 41():128026. PubMed ID: 33839252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel ketoxime ether derivatives with potent FXR agonistic activity, oral effectiveness and high liver/blood ratio.
    Tang X; Ning M; Ye Y; Gu Y; Yan H; Leng Y; Shen J
    Bioorg Med Chem; 2021 Aug; 43():116280. PubMed ID: 34256254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptochinones from Cryptocarya chinensis act as farnesoid X receptor agonists.
    Lin HR; Chou TH; Huang DW; Chen IS
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4181-6. PubMed ID: 25127166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists.
    Marinozzi M; Carotti A; Sansone E; Macchiarulo A; Rosatelli E; Sardella R; Natalini B; Rizzo G; Adorini L; Passeri D; De Franco F; Pruzanski M; Pellicciari R
    Bioorg Med Chem; 2012 Jun; 20(11):3429-45. PubMed ID: 22564381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of protostane triterpenoids in Alisma orientalis by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Liu X; Li SL; Zhou Y; Song JZ; Zheng YF; Peng GP; Xu HX
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1514-22. PubMed ID: 20486247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alisma orientale: Ethnopharmacology, Phytochemistry and Pharmacology of an Important Traditional Chinese Medicine.
    Shu Z; Pu J; Chen L; Zhang Y; Rahman K; Qin L; Zheng C
    Am J Chin Med; 2016; 44(2):227-51. PubMed ID: 27080939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.